drugset / Trial / NCT03594656
Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Lingzhi(Ganoderma) is widely used in traditional Chinese medicine. Previous studies indicated that Lingzhi was safe, well tolorated, and improved symptoms as an add-on therapy to levodopa in early Parkinson's disease(PD) patients. Here the investigators design a multicenter, randomized, double-blind, placebo-controlled, delayed-start trial to evaluate the effects of Lingzhi on modifying disease progression in untreated PD patients.
Timeline
- Start
- 2018-07-15
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LingZhi | Traditional medicine (herbal / TCM) | 0.8 g | — |